Skip to content

News & calendar

news: as of 2026-10-12
What the marks mean

Importance is a model-assigned 1–5 on published stories, not a market forecast.

Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.

An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.

Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.

Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.

A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.

Ahead

scheduled · today and tomorrow · calendar refreshed 2026-10-12

Mon · 12 Oct · today

Tue · 13 Oct

Behind

published · newest first

Mon · 13 Jul

partnership

18:26
Google News: Madrigal Pharmaceuticals

Madrigal Doubles Down On MASH With A $4.4 Billion Licensing Deal With China's Ribo

Madrigal Pharmaceuticals signed a $4.4 billion licensing deal with China's Ribo to expand its MASH portfolio.

Markets open original ↗

regulation

18:21
Google News: BioMarin Pharmaceutical Inc.

FDA accepts BioMarin application for full VOXZOGO approval

The FDA accepted BioMarin's application seeking full approval of Voxzogo.

Markets open original ↗

earnings

16:25
Google News: Kongsberg Gruppen

Kongsberg misses order intake estimates, shares slip

Kongsberg Gruppen missed order intake estimates and shares slipped in response.

Markets open original ↗

regulation

16:09
Google News: Amgen Inc.

Amgen Faces a July 29 Deadline to Save Tavneos From an FDA Withdrawal

Amgen faces a July 29 deadline to save its drug Tavneos from an FDA withdrawal.

Markets open original ↗

regulation

16:03
Google News: Sanofi

US FDA approves Sanofi's wearable injector form of blood cancer drug

The FDA approved a wearable on-body injector version of Sanofi's blood cancer drug.

Markets open original ↗

The wire

everything that arrived · 7 days